Why is Morepen Labs. falling/rising?

As of 20-Aug, Morepen Laboratories Ltd's stock price is currently at 49.74, reflecting an increase of 0.89 or 1.82%. The stock has shown a positive trend recently, gaining for the last three days with a total return of 7.18% during this period. However, despite this short-term gain, the stock has experienced a significant decline of 20.51% over the past month and a year-to-date drop of 36.48%. The company has a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.4, but it has also reported negative results in the last two quarters, with net sales falling by 8.72%. This combination of factors indicates that while the stock is currently rising, it faces underlying challenges that could impact its long-term performance.
In the broader market context, Morepen Laboratories Ltd has outperformed the Sensex by 2.24% today, which is notable given that the Sensex has only increased by 1.64% over the past week. However, the stock's long-term performance remains concerning, as it has underperformed the benchmark indices over various periods, including a 27.05% decline in the last year. Additionally, the lack of domestic mutual fund investment, which stands at 0%, suggests a lack of confidence from institutional investors, further complicating the stock's outlook. Overall, while the recent price increase may indicate some short-term optimism, the broader context reveals significant challenges that could hinder sustained growth.